These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8118925)

  • 21. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
    Styles JA; Davies A; Davies R; White IN; Smith LL
    Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver.
    Montandon F; Williams GM
    Arch Toxicol; 1994; 68(4):272-5. PubMed ID: 8067901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS; Kupfer D
    Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus.
    Li D; Dragan Y; Jordan VC; Wang M; Pitot HC
    Cancer Res; 1997 Apr; 57(8):1438-41. PubMed ID: 9108442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.
    Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M
    Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
    Dehal SS; Brodie AM; Kupfer D
    Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
    Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC
    Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence from 32P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse live: likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation.
    Moorthy B; Liehr J; Randerath E; Randerath K
    Carcinogenesis; 1995 Nov; 16(11):2643-8. PubMed ID: 7586180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
    Hemminki K; Widlak P; Hou SM
    Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol.
    Randerath K; Bi J; Mabon N; Sriram P; Moorthy B
    Carcinogenesis; 1994 May; 15(5):797-800. PubMed ID: 8200078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.
    Shibutani S; Dasaradhi L; Terashima I; Banoglu E; Duffel MW
    Cancer Res; 1998 Feb; 58(4):647-53. PubMed ID: 9485016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.
    Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S
    Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture.
    Sharma M; Shubert DE; Sharma M; Rodabaugh KJ; McGarrigle BP; Vezina CM; Bofinger DP; Olson JR
    Biochem Biophys Res Commun; 2003 Jul; 307(1):157-64. PubMed ID: 12849995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
    Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
    Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tamoxifen feeding on metabolic activation of tamoxifen by the liver of the rhesus monkey: does liver accumulation of inhibitory metabolites protect from tamoxifen-dependent genotoxicity and cancer?
    Comoglio A; Gibbs AH; White IN; Gant T; Martin EA; Smith LL; Gamalero SR; DeMatteis F
    Carcinogenesis; 1996 Aug; 17(8):1687-93. PubMed ID: 8761427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro.
    Surh YJ; Liem A; Miller EC; Miller JA
    Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.